A 16-week aerobic exercise and mindfulness-based intervention on chronic psychosocial stress: a pilot and feasibility study

por Prochilo, Guy A., Costa, Ricardo J.S., Hassed, Craig, Chambers, Richard, Molenberghs, Pascal
Publicado 2021

Targeting VEGF-VEGFR Pathway by Sunitinib in Peripheral Primitive Neuroectodermal Tumor, Paraganglioma and Epithelioid Hemangioendothelioma: Three Case Reports

por Prochilo, Tiziana, Savelli, Giordano, Bertocchi, Paola, Abeni, Chiara, Rota, Luigina, Rizzi, Anna, Zaniboni, Alberto
Publicado 2013

Neutropenic Enterocolitis in the Treatment of Solid Tumors: A Case Report and Review of the Literature

por Cherri, Sara, Prochilo, Tiziana, Rota, Luigina, Mutti, Stefano, Garatti, Marco, Liserre, Barbara, Zaniboni, Alberto
Publicado 2020

Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era

por Cherri, Sara, Noventa, Silvia, Fanelli, Martina, Calandra, Giulio, Prochilo, Tiziana, Bnà, Claudio, Savelli, Giordano, Zaniboni, Alberto
Publicado 2021

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)

por Baldini, E, Ardizzoni, A, Prochilo, T, Cafferata, M A, Boni, L, Tibaldi, C, Neumaier, C, Conte, P F, Rosso, R
Publicado 2001

Rab7a activation promotes degradation of select tight junction proteins at the blood-brain barrier after ischemic stroke

por Cottarelli, Azzurra, Shahriar, Sanjid, Arac, Ahmet, Glendinning, Michael, Tuohy, Mary Claire, Prochilo, Grace, Neal, Jason B., Edinger, Aimee L., Agalliu, Dritan
Publicado 2023

Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study

por Tibaldi, C, Prochilo, T, Russo, F, Pennucci, M C, Del Freo, A, Innocenti, F, Fabbri, A, Falcone, A, Conte, P F, Baldini, E
Publicado 2006

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

por Baldini, E, Prochilo, T, Salvadori, B, Bolognesi, A, Aldrighetti, D, Venturini, M, Rosso, R, Carnino, F, Gallo, L, Giannessi, P, Conte, P F, Orlandini, C, Bruzzi, P
Publicado 2004

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management

por Del Prete, Michela, Giampieri, Riccardo, Loupakis, Fotios, Prochilo, Tiziana, Salvatore, Lisa, Faloppi, Luca, Bianconi, Maristella, Bittoni, Alessandro, Aprile, Giuseppe, Zaniboni, Alberto, Falcone, Alfredo, Scartozzi, Mario, Cascinu, Stefano
Publicado 2015

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis

por Giampieri, Riccardo, Prete, Michela del, Prochilo, Tiziana, Puzzoni, Marco, Pusceddu, Valeria, Pani, Fabiana, Maccaroni, Elena, Mascia, Roberta, Baleani, Maria Giuditta, Meletani, Tania, Berardi, Rossana, Lanzillo, Anna Maria, Mariotti, Stefano, Zaniboni, Alberto, Cascinu, Stefano, Scartozzi, Mario
Publicado 2017

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial tr...

por Boni, C, Tiseo, M, Boni, L, Baldini, E, Recchia, F, Barone, C, Grossi, F, Germano, D, Matano, E, Marini, G, Labianca, R, Di Costanzo, F, Bagnulo, A, Pennucci, C, Caroti, C, Mencoboni, M, Zanelli, F, Prochilo, T, Cafferata, M A, Ardizzoni, A
Publicado 2012

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients

por Giampieri, Riccardo, Salvatore, Lisa, Del Prete, Michela, Prochilo, Tiziana, D’Anzeo, Marco, Loretelli, Cristian, Loupakis, Fotios, Aprile, Giuseppe, Maccaroni, Elena, Andrikou, Kalliopi, Bianconi, Maristella, Bittoni, Alessandro, Faloppi, Luca, Demurtas, Laura, Montironi, Rodolfo, Scarpelli, Marina, Falcone, Alfredo, Zaniboni, Alberto, Scartozzi, Mario, Cascinu, Stefano
Publicado 2016